4d Molecular Therapeutics Stock Price Prediction
| FDMT Stock | USD 7.84 0.03 0.38% |
Oversold Vs Overbought
50
Oversold | Overbought |
EPS Estimate Next Quarter (0.82) | EPS Estimate Current Year (2.92) | EPS Estimate Next Year (3.61) | Wall Street Target Price 45.6364 | EPS Estimate Current Quarter (0.70) |
Using 4D Molecular hype-based prediction, you can estimate the value of 4D Molecular Therapeutics from the perspective of 4D Molecular response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in 4D Molecular to buy its stock at a price that has no basis in reality. In that case, they are not buying FDMT because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
4D Molecular after-hype prediction price | USD 7.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
FDMT |
4D Molecular After-Hype Price Prediction Density Analysis
As far as predicting the price of 4D Molecular at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in 4D Molecular or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of 4D Molecular, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
4D Molecular Estimiated After-Hype Price Volatility
In the context of predicting 4D Molecular's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on 4D Molecular's historical news coverage. 4D Molecular's after-hype downside and upside margins for the prediction period are 3.58 and 11.88, respectively. We have considered 4D Molecular's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4D Molecular is somewhat reliable at this time. Analysis and calculation of next after-hype price of 4D Molecular Therapeutics is based on 3 months time horizon.
4D Molecular Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as 4D Molecular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 4D Molecular backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with 4D Molecular, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.89 | 4.15 | 0.11 | 0.09 | 10 Events / Month | 14 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
7.84 | 7.73 | 1.40 |
|
4D Molecular Hype Timeline
4D Molecular Therapeutics is currently traded for 7.84. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.09. FDMT is expected to decline in value after the next headline, with the price expected to drop to 7.73. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.4%, whereas the daily expected return is currently at -0.89%. The volatility of related hype on 4D Molecular is about 4194.15%, with the expected price after the next announcement by competition of 7.93. About 96.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. 4D Molecular Therapeutics recorded a loss per share of 2.85. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out 4D Molecular Basic Forecasting Models to cross-verify your projections.4D Molecular Related Hype Analysis
Having access to credible news sources related to 4D Molecular's direct competition is more important than ever and may enhance your ability to predict 4D Molecular's future price movements. Getting to know how 4D Molecular's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how 4D Molecular may potentially react to the hype associated with one of its peers.
4D Molecular Additional Predictive Modules
Most predictive techniques to examine FDMT price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for FDMT using various technical indicators. When you analyze FDMT charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About 4D Molecular Predictive Indicators
The successful prediction of 4D Molecular stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as 4D Molecular Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of 4D Molecular based on analysis of 4D Molecular hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to 4D Molecular's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to 4D Molecular's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 19.31 | 14.02 | 15.65 | 9.8 | Net Debt To EBITDA | 4.38 | 1.91 | 2.19 | 4.14 |
Story Coverage note for 4D Molecular
The number of cover stories for 4D Molecular depends on current market conditions and 4D Molecular's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that 4D Molecular is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about 4D Molecular's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
4D Molecular Short Properties
4D Molecular's future price predictability will typically decrease when 4D Molecular's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of 4D Molecular Therapeutics often depends not only on the future outlook of the potential 4D Molecular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 4D Molecular's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.1 M | |
| Cash And Short Term Investments | 288.2 M |
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.